Confidential Document Reveals Pfizer and Health Authorities Covered Risks to Pregnant Women? – Liberation

The document in question appears to be an official recommendation from the UK Department of Health dated December 2020, reflecting the state of knowledge at the time.

In early January, a Texas federal judge ordered the Food and Drug Administration (FDA) to make public, within eight months, all the data it relied on to approve Pfizer’s Covid-19 vaccine. The progressive publication of these thousands of “Pfizer Documents” is inevitably accompanied by cookie-cutter analysis of some Internet users. This is the case with the topic you are asking us about. Many Twitter messages ensure that these “Pfizer documents” reveal that the laboratory had identified the danger of its vaccine to pregnant and lactating women and that the information would be ignored by the FDA. In support of this accusation, an annotated screenshot, taken at will by countless accounts.

A screenshot of a document, presumably from recently uploaded files, is particularly shared. Several segments of the text are highlighted (in English): “There are no or limited data on the use of the COVID-19 mRNA BNT162b2 vaccine. Reproductive toxicity studies in animals have not been completed. [Ce vaccin] not recommended during pregnancy “Where “It is not known whether COVID-19 BNT162b2 mRNA vaccine is excreted in human milk and a risk to the newborns / infants cannot be excluded.”

There is nothing confidential or unpublished about this document, as it is a document “To the attention of healthcare professionals in the UK” published across the Channel on 5 December 2020 on the Ministry of Health website, whose archive is still available at this address. It reflects the state of knowledge on the subject at the time of publication. However, as we wrote in our December 9, 2020 article on the first results of Pfizer clinical trials, “Pregnant or breastfeeding women [avaient] were excluded from the tests.which then made it impossible to jeopardize its safety profile for this population category.

Favorable risk / benefit ratio

Therefore, this is not a risk identified by Pfizer and concealed by it, but a lack of information notoriously recognized by the laboratory and the medical community following clinical trials carried out in 2020. Since then, a worldwide vaccination campaign has made women unaware that she is pregnant receiving the vaccine. The monitoring of these populations has progressively led the medical community to believe that this injection presents a favorable risk / benefit ratio for pregnant women, in particular as regards the potentially deleterious consequences of an infection on pregnancy, in particular starting from third quarter.

Access to priority vaccination for pregnant women from the second trimester (with or without comorbidities) was decided on April 3, 2021 by the DGS in the light of the data then available. Until then, the High Authority for Health (HAS) has indicated this the administration of vaccines against Covid-19 in pregnant women was not “not contraindicated” : “Consideration must be given to whether the potential benefits outweigh the risks to the mother and fetus. In particular, vaccination may be offered to pregnant women over the age of 35 or to those with other comorbidities such as obesity, diabetes or cardiovascular disease.

During 2021, new observational studies (Israeli, American and Norwegian) confirmed that Covid-19 mRNA vaccines administered during pregnancy were not associated with an increased risk of obstetric complications (spontaneous abortion, prematurity, etc.). Results further strengthened at the end of March 2022 with the publication of large-scale studies in Journal of the American Medical Association. As regards breastfeeding, the presence of post-vaccination antibodies in breast milk is now established, with an expected benefit on the protection of the newborn. In fact, no contraindication is formulated by the WHO on this subject.

Declaration to be verified

A screenshot of a confidential document reveals that Pfizer hid the dangers of its vaccine to pregnant and lactating women.

Conclusion

Impostor. This is a public document released by the UK Department of Health in December 2020, reflecting the lack of knowledge on the subject prior to the vaccination campaign, duly cited in the press at the time.

Leave a Comment